Financial Wire

Raymond James Initiates United Therapeutics at Outperform

United Therapeutics (UTHR) has an average rating of overweight and mean price target of $654.42, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

-- United Therapeutics (UTHR) has an average rating of overweight and mean price target of $654.42, according to analysts polled by FactSet.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)